Koninklijke Philips N.V.
Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.
Publicatie datum
15 jul 2009 - 14:13
Statutaire naam
Koninklijke Philips N.V.
Titel
Philips expands emergency healthcare offering with acquisition of InnerCool Therapies; a leader in body temperature management
Bericht
July 15, 2009
PHILIPS EXPANDS EMERGENCY HEALTHCARE OFFERING WITH ACQUISITION OF INNERCOOL THERAPIES; A LEADER IN BODY TEMPERATURE MANAGEMENT
Amsterdam, the Netherlands and San Diego, USA – Royal Philips (AEX: PHI, NYSE: PHG) announced today that it has reached an agreement to acquire the assets of InnerCool Therapies Inc., a pioneer in the field of therapeutic hypothermia, which involves the management of a patient’s body temperature. InnerCool, a wholly-owned subsidiary of Cardium Therapeutics, Inc. (NYSE Amex: CXM), will be acquired in an asset purchase transaction for US $11.25 million, as well as the transfer of approximately US $1.5 million in trade payables. The transaction will reinforce Philips’ leadership position in the emergency care market by adding body temperature management solutions to its existing product offering in this field.
“This acquisition is another example of our continuous strategy to focus on a patient’s cycle of care.” said Steve Rusckowski, chief executive officer of Philips Healthcare. “With InnerCool, Philips is acquiring a true innovator in the field of temperature management. This will allow us to broaden our offering in emergency care now, and also enable us to provide leadership in promising future applications such as acute myocardial infarction and stroke, which could further preserve heart and brain tissue.”
Therapeutic hypothermia solutions aim to safely induce, maintain and reverse hypothermia or maintain normal body temperature, to preserve organs such as the heart and brain in the event of Sudden Cardiac Arrest (SCA). This rapidly-advancing technology has been recognized by the American Heart Association and the International Liaison Committee on Resuscitation as crucial in improving the survival and neurological recovery for SCA patients.
InnerCool Therapies will position Philips for continued growth in the cardiology care cycle by enhancing its industry-leading emergency care solutions offered globally. Today this i
Datum laatste update: 21 december 2025